 | • レポートコード：QAF27621 • 出版社/出版日：QYResearch / 2021年3月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のCSF (豚熱) ワクチン市場について種類別（組織培養起源、細胞株起源）、用途別（政府入札、市場販売）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・CSF (豚熱) ワクチン市場の概要 ・世界の主要地域別CSF (豚熱) ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のCSF (豚熱) ワクチン市場規模2016-2021：種類別（組織培養起源、細胞株起源） ・世界のCSF (豚熱) ワクチン市場予測2012-2027：種類別（組織培養起源、細胞株起源） ・世界のCSF (豚熱) ワクチン市場規模2016-2021：用途別（政府入札、市場販売） ・世界のCSF (豚熱) ワクチン市場予測2012-2027：用途別（政府入札、市場販売） ・CSF (豚熱) ワクチンのアメリカ市場規模と予測2016-2021 ・CSF (豚熱) ワクチンのヨーロッパ市場規模と予測2016-2021 ・CSF (豚熱) ワクチンの中国市場規模と予測2016-2021 ・CSF (豚熱) ワクチンの日本市場規模と予測2016-2021 ・CSF (豚熱) ワクチンの東南アジア市場規模と予測2016-2021 ・CSF (豚熱) ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （WINSUN、CAHIC、Merial、MSD Animal Health、Chopper Biology、Ceva、ChengDu Tecbond、Veterinary、Ringpu Biology、Qilu Animal、DHN、CAVAC、Komipharm、Agrovet、Bioveta、Jinyu Bio-Technology、Institutul Pasteur、MVP、Tecon） ・CSF (豚熱) ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・CSF (豚熱) ワクチンの市場動向・機会・課題 ・調査の結論 |
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is about 60%. And the proportion of Cell Line Origin in 2016 is about 40%. Market competition is intense WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Classical Swine Fever Vaccines industry will be more and more popular in the future.
Market Analysis and Insights: Global Classical Swine Fever Vaccines Market
The global Classical Swine Fever Vaccines market was valued at US$ 152.1 in 2020 and will reach US$ 178.5 million by the end of 2027, growing at a CAGR of 2.7% during 2022-2027.
Global Classical Swine Fever Vaccines Scope and Market Size
The global Classical Swine Fever Vaccines market is segmented by company, region (country), by Source, and by Sales Channel. Players, stakeholders, and other participants in the global Classical Swine Fever Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Source and by Sales Channel for the period 2016-2027.
Segment by Source
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel
Government Tender
Market Sales
The Classical Swine Fever Vaccines market is analysed and market size information is provided by regions (countries). Segment by Sales Channel, the Classical Swine Fever Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
1 Classical Swine Fever Vaccines Market Overview
1.1 Classical Swine Fever Vaccines Product Scope
1.2 Classical Swine Fever Vaccines Segment by Source
1.2.1 Global Classical Swine Fever Vaccines Sales by Source (2016 & 2021 & 2027)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Classical Swine Fever Vaccines Segment by Sales Channel
1.3.1 Global Classical Swine Fever Vaccines Sales Comparison by Sales Channel (2016 & 2021 & 2027)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Classical Swine Fever Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Classical Swine Fever Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Classical Swine Fever Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Classical Swine Fever Vaccines Price Trends (2016-2027)
2 Classical Swine Fever Vaccines Estimates and Forecasts by Region
2.1 Global Classical Swine Fever Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Classical Swine Fever Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Classical Swine Fever Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Classical Swine Fever Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
2.4.3 China Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
2.4.6 India Classical Swine Fever Vaccines Estimates and Projections (2016-2027)
3 Global Classical Swine Fever Vaccines Competition Landscape by Players
3.1 Global Top Classical Swine Fever Vaccines Players by Sales (2016-2021)
3.2 Global Top Classical Swine Fever Vaccines Players by Revenue (2016-2021)
3.3 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2020)
3.4 Global Classical Swine Fever Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Classical Swine Fever Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Classical Swine Fever Vaccines Market Size by Source
4.1 Global Classical Swine Fever Vaccines Historic Market Review by Source (2016-2021)
4.1.1 Global Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
4.1.2 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2016-2021)
4.1.3 Global Classical Swine Fever Vaccines Price by Source (2016-2021)
4.2 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Source (2022-2027)
4.2.1 Global Classical Swine Fever Vaccines Sales Forecast by Source (2022-2027)
4.2.2 Global Classical Swine Fever Vaccines Revenue Forecast by Source (2022-2027)
4.2.3 Global Classical Swine Fever Vaccines Price Forecast by Source (2022-2027)
5 Global Classical Swine Fever Vaccines Market Size by Sales Channel
5.1 Global Classical Swine Fever Vaccines Historic Market Review by Sales Channel (2016-2021)
5.1.1 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
5.1.2 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2016-2021)
5.1.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2016-2021)
5.2 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Sales Channel (2022-2027)
5.2.1 Global Classical Swine Fever Vaccines Sales Forecast by Sales Channel (2022-2027)
5.2.2 Global Classical Swine Fever Vaccines Revenue Forecast by Sales Channel (2022-2027)
5.2.3 Global Classical Swine Fever Vaccines Price Forecast by Sales Channel (2022-2027)
6 North America Classical Swine Fever Vaccines Market Facts & Figures
6.1 North America Classical Swine Fever Vaccines Sales by Company
6.1.1 North America Classical Swine Fever Vaccines Sales by Company (2016-2021)
6.1.2 North America Classical Swine Fever Vaccines Revenue by Company (2016-2021)
6.2 North America Classical Swine Fever Vaccines Sales Breakdown by Source
6.2.1 North America Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
6.2.2 North America Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
6.3 North America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
6.3.1 North America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2016-2021)
6.3.2 North America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2022-2027)
7 Europe Classical Swine Fever Vaccines Market Facts & Figures
7.1 Europe Classical Swine Fever Vaccines Sales by Company
7.1.1 Europe Classical Swine Fever Vaccines Sales by Company (2016-2021)
7.1.2 Europe Classical Swine Fever Vaccines Revenue by Company (2016-2021)
7.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Source
7.2.1 Europe Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
7.2.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
7.3 Europe Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
7.3.1 Europe 148 Sales Breakdown by Sales Channel (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Sales Channel (2022-2027)
8 China Classical Swine Fever Vaccines Market Facts & Figures
8.1 China Classical Swine Fever Vaccines Sales by Company
8.1.1 China Classical Swine Fever Vaccines Sales by Company (2016-2021)
8.1.2 China Classical Swine Fever Vaccines Revenue by Company (2016-2021)
8.2 China Classical Swine Fever Vaccines Sales Breakdown by Source
8.2.1 China Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
8.2.2 China Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
8.3 China Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
8.3.1 China 312 Sales Breakdown by Sales Channel (2016-2021)
8.3.2 China 312 Sales Breakdown by Sales Channel (2022-2027)
9 Japan Classical Swine Fever Vaccines Market Facts & Figures
9.1 Japan Classical Swine Fever Vaccines Sales by Company
9.1.1 Japan Classical Swine Fever Vaccines Sales by Company (2016-2021)
9.1.2 Japan Classical Swine Fever Vaccines Revenue by Company (2016-2021)
9.2 Japan Classical Swine Fever Vaccines Sales Breakdown by Source
9.2.1 Japan Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
9.2.2 Japan Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
9.3 Japan Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
9.3.1 Japan Jan. Sales Breakdown by Sales Channel (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Sales Channel (2022-2027)
10 Southeast Asia Classical Swine Fever Vaccines Market Facts & Figures
10.1 Southeast Asia Classical Swine Fever Vaccines Sales by Company
10.1.1 Southeast Asia Classical Swine Fever Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Classical Swine Fever Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Classical Swine Fever Vaccines Sales Breakdown by Source
10.2.1 Southeast Asia Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
10.2.2 Southeast Asia Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
10.3 Southeast Asia Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
10.3.1 Southeast Asia M Doses Sales Breakdown by Sales Channel (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Sales Channel (2022-2027)
11 India Classical Swine Fever Vaccines Market Facts & Figures
11.1 India Classical Swine Fever Vaccines Sales by Company
11.1.1 India Classical Swine Fever Vaccines Sales by Company (2016-2021)
11.1.2 India Classical Swine Fever Vaccines Revenue by Company (2016-2021)
11.2 India Classical Swine Fever Vaccines Sales Breakdown by Source
11.2.1 India Classical Swine Fever Vaccines Sales Breakdown by Source (2016-2021)
11.2.2 India Classical Swine Fever Vaccines Sales Breakdown by Source (2022-2027)
11.3 India Classical Swine Fever Vaccines Sales Breakdown by Sales Channel
11.3.1 India Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2016-2021)
11.3.2 India Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2022-2027)
12 Company Profiles and Key Figures in Classical Swine Fever Vaccines Business
12.1 WINSUN
12.1.1 WINSUN Corporation Information
12.1.2 WINSUN Business Overview
12.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 WINSUN Classical Swine Fever Vaccines Products Offered
12.1.5 WINSUN Recent Development
12.2 CAHIC
12.2.1 CAHIC Corporation Information
12.2.2 CAHIC Business Overview
12.2.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CAHIC Classical Swine Fever Vaccines Products Offered
12.2.5 CAHIC Recent Development
12.3 Merial
12.3.1 Merial Corporation Information
12.3.2 Merial Business Overview
12.3.3 Merial Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merial Classical Swine Fever Vaccines Products Offered
12.3.5 Merial Recent Development
12.4 MSD Animal Health
12.4.1 MSD Animal Health Corporation Information
12.4.2 MSD Animal Health Business Overview
12.4.3 MSD Animal Health Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 MSD Animal Health Classical Swine Fever Vaccines Products Offered
12.4.5 MSD Animal Health Recent Development
12.5 Chopper Biology
12.5.1 Chopper Biology Corporation Information
12.5.2 Chopper Biology Business Overview
12.5.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chopper Biology Classical Swine Fever Vaccines Products Offered
12.5.5 Chopper Biology Recent Development
12.6 Ceva
12.6.1 Ceva Corporation Information
12.6.2 Ceva Business Overview
12.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ceva Classical Swine Fever Vaccines Products Offered
12.6.5 Ceva Recent Development
12.7 ChengDu Tecbond
12.7.1 ChengDu Tecbond Corporation Information
12.7.2 ChengDu Tecbond Business Overview
12.7.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ChengDu Tecbond Classical Swine Fever Vaccines Products Offered
12.7.5 ChengDu Tecbond Recent Development
12.8 Veterinary
12.8.1 Veterinary Corporation Information
12.8.2 Veterinary Business Overview
12.8.3 Veterinary Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Veterinary Classical Swine Fever Vaccines Products Offered
12.8.5 Veterinary Recent Development
12.9 Ringpu Biology
12.9.1 Ringpu Biology Corporation Information
12.9.2 Ringpu Biology Business Overview
12.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Ringpu Biology Classical Swine Fever Vaccines Products Offered
12.9.5 Ringpu Biology Recent Development
12.10 Qilu Animal
12.10.1 Qilu Animal Corporation Information
12.10.2 Qilu Animal Business Overview
12.10.3 Qilu Animal Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Qilu Animal Classical Swine Fever Vaccines Products Offered
12.10.5 Qilu Animal Recent Development
12.11 DHN
12.11.1 DHN Corporation Information
12.11.2 DHN Business Overview
12.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 DHN Classical Swine Fever Vaccines Products Offered
12.11.5 DHN Recent Development
12.12 CAVAC
12.12.1 CAVAC Corporation Information
12.12.2 CAVAC Business Overview
12.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CAVAC Classical Swine Fever Vaccines Products Offered
12.12.5 CAVAC Recent Development
12.13 Komipharm
12.13.1 Komipharm Corporation Information
12.13.2 Komipharm Business Overview
12.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Komipharm Classical Swine Fever Vaccines Products Offered
12.13.5 Komipharm Recent Development
12.14 Agrovet
12.14.1 Agrovet Corporation Information
12.14.2 Agrovet Business Overview
12.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Agrovet Classical Swine Fever Vaccines Products Offered
12.14.5 Agrovet Recent Development
12.15 Bioveta
12.15.1 Bioveta Corporation Information
12.15.2 Bioveta Business Overview
12.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Bioveta Classical Swine Fever Vaccines Products Offered
12.15.5 Bioveta Recent Development
12.16 Jinyu Bio-Technology
12.16.1 Jinyu Bio-Technology Corporation Information
12.16.2 Jinyu Bio-Technology Business Overview
12.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Products Offered
12.16.5 Jinyu Bio-Technology Recent Development
12.17 Institutul Pasteur
12.17.1 Institutul Pasteur Corporation Information
12.17.2 Institutul Pasteur Business Overview
12.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Institutul Pasteur Classical Swine Fever Vaccines Products Offered
12.17.5 Institutul Pasteur Recent Development
12.18 MVP
12.18.1 MVP Corporation Information
12.18.2 MVP Business Overview
12.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 MVP Classical Swine Fever Vaccines Products Offered
12.18.5 MVP Recent Development
12.19 Tecon
12.19.1 Tecon Corporation Information
12.19.2 Tecon Business Overview
12.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Tecon Classical Swine Fever Vaccines Products Offered
12.19.5 Tecon Recent Development
13 Classical Swine Fever Vaccines Manufacturing Cost Analysis
13.1 Classical Swine Fever Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Classical Swine Fever Vaccines
13.4 Classical Swine Fever Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Classical Swine Fever Vaccines Distributors List
14.3 Classical Swine Fever Vaccines Customers
15 Market Dynamics
15.1 Classical Swine Fever Vaccines Market Trends
15.2 Classical Swine Fever Vaccines Drivers
15.3 Classical Swine Fever Vaccines Market Challenges
15.4 Classical Swine Fever Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Classical Swine Fever Vaccines Sales (US$ Million) Growth Rate by Source (2016 & 2021 & 2027)
Table 2. Global Classical Swine Fever Vaccines Sales ((US$ Million)) Comparison by Sales Channel (2016 & 2021 & 2027)
Table 3. Global Classical Swine Fever Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Classical Swine Fever Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Classical Swine Fever Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Classical Swine Fever Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Classical Swine Fever Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Classical Swine Fever Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Classical Swine Fever Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Classical Swine Fever Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Classical Swine Fever Vaccines Sales Share by Company (2016-2021)
Table 14. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Classical Swine Fever Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Classical Swine Fever Vaccines as of 2020)
Table 17. Global Classical Swine Fever Vaccines Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Classical Swine Fever Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Classical Swine Fever Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2016-2021)
Table 22. Global Classical Swine Fever Vaccines Sales Share by Source (2016-2021)
Table 23. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Source (2016-2021)
Table 24. Global Classical Swine Fever Vaccines Price (USD/K Doses) by Source (2016-2021)
Table 25. Global Classical Swine Fever Vaccines Sales Share by Source (2022-2027)
Table 26. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Source (2022-2027)
Table 27. Global Classical Swine Fever Vaccines Revenue Share by Source (2022-2027)
Table 28. Global Classical Swine Fever Vaccines Price (USD/K Doses) by Source (2022-2027)
Table 29. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2016-2021)
Table 30. Global Classical Swine Fever Vaccines Sales Share by Sales Channel (2016-2021)
Table 31. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Sales Channel (2016-2021)
Table 32. Global Classical Swine Fever Vaccines Price (USD/K Doses) by Sales Channel (2016-2021)
Table 33. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2022-2027)
Table 34. Global Classical Swine Fever Vaccines Sales Share by Sales Channel (2022-2027)
Table 35. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Sales Channel (2022-2027)
Table 36. Global Classical Swine Fever Vaccines Revenue Share by Sales Channel (2022-2027)
Table 37. Global Classical Swine Fever Vaccines Price (USD/K Doses) by Sales Channel (2022-2027)
Table 38. North America Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 43. North America Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 44. North America Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 45. North America Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 46. North America Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 47. North America Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 48. North America Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 49. North America Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 50. Europe Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 55. Europe Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 56. Europe Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 57. Europe Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 58. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 59. Europe Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 60. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 61. Europe Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 62. China Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 67. China Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 68. China Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 69. China Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 70. China Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 71. China Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 72. China Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 73. China Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 74. Japan Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 79. Japan Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 80. Japan Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 81. Japan Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 82. Japan Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 83. Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 84. Japan Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 85. Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 86. Southeast Asia Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 91. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 92. Southeast Asia Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 93. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 94. Southeast Asia Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 95. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 96. Southeast Asia Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 97. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 98. India Classical Swine Fever Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Classical Swine Fever Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Classical Swine Fever Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Classical Swine Fever Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Classical Swine Fever Vaccines Sales by Source (2016-2021) & (M Doses)
Table 103. India Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
Table 104. India Classical Swine Fever Vaccines Sales by Source (2022-2027) & (M Doses)
Table 105. India Classical Swine Fever Vaccines Sales Market Share by Source (2022-2027)
Table 106. India Classical Swine Fever Vaccines Sales by Sales Channel (2016-2021) & (M Doses)
Table 107. India Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
Table 108. India Classical Swine Fever Vaccines Sales by Sales Channel (2022-2027) & (M Doses)
Table 109. India Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2022-2027)
Table 110. WINSUN Corporation Information
Table 111. WINSUN Description and Business Overview
Table 112. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. WINSUN Classical Swine Fever Vaccines Product
Table 114. WINSUN Recent Development
Table 115. CAHIC Corporation Information
Table 116. CAHIC Description and Business Overview
Table 117. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. CAHIC Classical Swine Fever Vaccines Product
Table 119. CAHIC Recent Development
Table 120. Merial Corporation Information
Table 121. Merial Description and Business Overview
Table 122. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Merial Classical Swine Fever Vaccines Product
Table 124. Merial Recent Development
Table 125. MSD Animal Health Corporation Information
Table 126. MSD Animal Health Description and Business Overview
Table 127. MSD Animal Health Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. MSD Animal Health Classical Swine Fever Vaccines Product
Table 129. MSD Animal Health Recent Development
Table 130. Chopper Biology Corporation Information
Table 131. Chopper Biology Description and Business Overview
Table 132. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Chopper Biology Classical Swine Fever Vaccines Product
Table 134. Chopper Biology Recent Development
Table 135. Ceva Corporation Information
Table 136. Ceva Description and Business Overview
Table 137. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. Ceva Classical Swine Fever Vaccines Product
Table 139. Ceva Recent Development
Table 140. ChengDu Tecbond Corporation Information
Table 141. ChengDu Tecbond Description and Business Overview
Table 142. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. ChengDu Tecbond Classical Swine Fever Vaccines Product
Table 144. ChengDu Tecbond Recent Development
Table 145. Veterinary Corporation Information
Table 146. Veterinary Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. Veterinary Description and Business Overview
Table 148. Veterinary Classical Swine Fever Vaccines Product
Table 149. Veterinary Recent Development
Table 150. Ringpu Biology Corporation Information
Table 151. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. Ringpu Biology Description and Business Overview
Table 153. Ringpu Biology Classical Swine Fever Vaccines Product
Table 154. Ringpu Biology Recent Development
Table 155. Qilu Animal Corporation Information
Table 156. Qilu Animal Description and Business Overview
Table 157. Qilu Animal Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 158. Qilu Animal Classical Swine Fever Vaccines Product
Table 159. Qilu Animal Recent Development
Table 160. DHN Corporation Information
Table 161. DHN Description and Business Overview
Table 162. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 163. DHN Classical Swine Fever Vaccines Product
Table 164. DHN Recent Development
Table 165. CAVAC Corporation Information
Table 166. CAVAC Description and Business Overview
Table 167. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 168. CAVAC Classical Swine Fever Vaccines Product
Table 169. CAVAC Recent Development
Table 170. Komipharm Corporation Information
Table 171. Komipharm Description and Business Overview
Table 172. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 173. Komipharm Classical Swine Fever Vaccines Product
Table 174. Komipharm Recent Development
Table 175. Agrovet Corporation Information
Table 176. Agrovet Description and Business Overview
Table 177. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 178. Agrovet Classical Swine Fever Vaccines Product
Table 179. Agrovet Recent Development
Table 180. Bioveta Corporation Information
Table 181. Bioveta Description and Business Overview
Table 182. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 183. Bioveta Classical Swine Fever Vaccines Product
Table 184. Bioveta Recent Development
Table 185. Jinyu Bio-Technology Corporation Information
Table 186. Jinyu Bio-Technology Description and Business Overview
Table 187. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 188. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
Table 189. Jinyu Bio-Technology Recent Development
Table 190. Institutul Pasteur Corporation Information
Table 191. Institutul Pasteur Description and Business Overview
Table 192. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 193. Institutul Pasteur Classical Swine Fever Vaccines Product
Table 194. Institutul Pasteur Recent Development
Table 195. MVP Corporation Information
Table 196. MVP Description and Business Overview
Table 197. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 198. MVP Classical Swine Fever Vaccines Product
Table 199. MVP Recent Development
Table 200. Tecon Corporation Information
Table 201. Tecon Description and Business Overview
Table 202. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 203. Tecon Classical Swine Fever Vaccines Product
Table 204. Tecon Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Classical Swine Fever Vaccines Distributors List
Table 208. Classical Swine Fever Vaccines Customers List
Table 209. Classical Swine Fever Vaccines Market Trends
Table 210. Classical Swine Fever Vaccines Market Drivers
Table 211. Classical Swine Fever Vaccines Market Challenges
Table 212. Classical Swine Fever Vaccines Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Classical Swine Fever Vaccines Product Picture
Figure 2. Global Classical Swine Fever Vaccines Sales Market Share by Source in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2021 & 2027
Figure 6. Government Tender Examples
Figure 7. Market Sales Examples
Figure 8. Global Classical Swine Fever Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Classical Swine Fever Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Classical Swine Fever Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Classical Swine Fever Vaccines Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 12. Global Classical Swine Fever Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Classical Swine Fever Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Classical Swine Fever Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Classical Swine Fever Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Classical Swine Fever Vaccines Players Market Share by Revenue in Classical Swine Fever Vaccines: 2016 & 2020
Figure 27. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Classical Swine Fever Vaccines Revenue Share by Source (2016-2021)
Figure 29. Global Classical Swine Fever Vaccines Revenue Growth Rate by Source in 2016 & 2020
Figure 30. Global Classical Swine Fever Vaccines Revenue Share by Sales Channel (2016-2021)
Figure 31. Global Classical Swine Fever Vaccines Revenue Growth Rate by Sales Channel in 2016 & 2020
Figure 32. North America Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 33. North America Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 34. Europe Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 35. Europe Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 36. China Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 37. China Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 38. Japan Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 39. Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 40. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 41. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 42. India Classical Swine Fever Vaccines Sales Market Share by Source in 2020
Figure 43. India Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Classical Swine Fever Vaccines
Figure 46. Manufacturing Process Analysis of Classical Swine Fever Vaccines
Figure 47. Classical Swine Fever Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
リフトバレー熱ワクチンのグローバル市場調査 2019年 The global Rift Valley Fever Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rift Valley Fever Vaccines volume and value at global level, regional level and company level. From a global per…- リフトバレー熱ワクチンのグローバル市場調査 2019年 The global Rift Valley Fever Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rift Valley Fever Vaccines volume and value at global level, regional level and company level. From a global per…
- 世界の豚流行性下痢ワクチン市場規模・現状・予測（2021年-2027年） Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease. Market Analysis and Insights: Global Swine Epidemic Diarrhea Vaccines Market The global Swine Epidemic Diarrhea Vaccines market size is projected to …
- 豚用ワクチンのグローバル市場2021 The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Vaccines contain antigens from vi…
- 世界の黄熱病治療市場規模・現状・予測（2021年-2027年） Yellow fever is an acute infectious disease caused by yellow fever virus, mainly transmitted by the bite of aedes mosquitoes. Clinical high fever, headache, jaundice, proteinuria, relatively slow pulse and bleeding as the main manifestations. Market Analysis and Insights: Global Yellow Fever Treatme…